Peter Scott Chin

Insider activity · 24 months0 buys1 saleCumulative net flow

Dec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 1 saleOct 26 · 0 buys · 0 salesNov 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (1 ops.)

€32k

Latest filing published 09 Sept 2026 for Denali Therapeutics Inc., €32k.

Filing timeline

BuySale

Peter Scott Chin

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Peter Scott Chin: trading record in brief

Our data holds just one disclosure by Peter Scott Chin, dated 9 September 2026, reporting an open-market sale worth €32k in Denali Therapeutics Inc. Further filings will be added here. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Peter Scott Chin

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Denali Therapeutics Inc. (US)

Declarations1 total

▼
Peter Scott Chin
Chief Medical OfficerExecutives4 Sept 2026Denali Therapeutics Inc.
36,868 USD0SEC
1,654 shares@ US$22.29Common StockSEC:0002124755-26-000007:0

1 of 1 declaration

Peter Scott Chin

Insider track record

Peter Scott Chin: trading record in brief

Companies and markets linked to Peter Scott Chin

Similar companies

Related executives